Table 2. Correlation between ITGA11/Jab1 and clinicopathological parameters.

Variable	ITGA11 postive cells %	P value	Jab1 postive cells %	P value
Age
<60	35.4 ± 20.2	0.854	34.5 ± 22.2	0.972
≥60	36.5 ± 15.4		34.8 ± 28.4
Histological type
Ductal	36.3 ± 19.4	0.310	34.5 ± 23.6	0.921
Lobular & Medullary	27.8 ± 19.4		35.5 ± 19.4
Stage
I	25.9 ± 13.2	0.210	26.1 ± 17.7	0.104
II	37.8 ± 17.8		39.0 ± 25.6
III & IV	35.2 ± 24.9		28.7 ± 17.7
Grade
G1	20.0 ± 10.5	0.044	26.7 ± 22.4	0.040
G2	34.9 ± 16.0		31.4 ± 15.0
G3	42.1 ± 26.4		45.7 ± 35.9
Tumor size
T1	26.7 ± 10.8	0.314	26.1 ± 15.5	0.100
T2	37.4 ± 18.4		39.1 ± 25.9
T3 & T4	35.3 ± 23.4		28.5 ± 17.3
LN metastasis
No	30.0 ± 15.7	0.235	35.1 ± 24.4	0.922
Yes	36.8 ± 20.0		34.5 ± 23.1
HER2
negative	36.8 ± 22.7	0.597	36.9 ± 22.6	0.395
positive	34.5 ± 16.1		32.5 ± 23.8
ER
negative	33.2 ± 18.3	0.262	27.5 ± 20.0	0.005
positive	38.1 ± 20.3		41.7 ± 24.2
PR
negative	34.8 ± 16.5	0.646	30.0 ± 22.1	0.039
positive	36.8 ± 22.9		40.8 ± 23.5
Ki-67
<14%	36.3 ± 17.3	0.752	34.5 ± 25.8	0.985
≥14%	34.9 ± 21.4		34.6 ± 20.7
Family history
No	37.8 ± 21.3	0.123	37.4 ± 23.2	0.092
Yes	30.5 ± 13.1		27.9 ± 22.2
Menopause
No	35.1 ± 20.5	0.773	36.6 ± 23.7	0.387
Yes	36.3 ± 18.2		32.0 ± 22.6

Abbreviations: LN: lymph node.